Bintrafusp alfa

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Bintrafusp alfa
Accession Number
DB15387
Type
Biotech
Groups
Investigational
Description

Bintrafusp alfa is under investigation in clinical trial NCT03833661 (M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)).

Synonyms
Not Available
Categories
Not Available
UNII
NW9K8C1JN3
CAS number
1918149-01-5

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1RecruitingTreatmentAnatomic Stage IV Breast Cancer AJCC v8 / Estrogen Receptor Positive / HER2/Neu Negative / Malignant Neoplasm of Breast / Metastatic Breast Carcinoma / Progesterone Receptor Positive / Prognostic Stage IV Breast Cancer AJCC v81
1, 2Not Yet RecruitingTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
1, 2Not Yet RecruitingTreatmentRecurrent Head and Neck Squamous Cell Carcinoma / Second Primary Squamous Cell Carcinoma of the Head and Neck / Squamous Cell Carcinoma of the Head and Neck Arising in a Previously Radiated Region1
1, 2RecruitingTreatmentAdenocarcinoma of the Colon / Adenocarcinoma of the Rectum / Colon Adenocarcinoma / High-Frequency Microsatellite Instability / Metastatic Malignant Solid Neoplasm / Rectal Adenocarcinoma / Refractory Colorectal Carcinoma / Stage IV Colon Cancer AJCC v8 / Stage IV Rectal Cancer AJCC v8 / Stage IVA Colon Cancer AJCC v8 / Stage IVA Rectal Cancer AJCC v8 / Stage IVB Colon Cancer AJCC v8 / Stage IVB Rectal Cancer AJCC v81
2Not Yet RecruitingTreatmentImmunotherapy / Nasopharyngeal Carcinoma / NPC1
2Not Yet RecruitingTreatmentUterine Cervical Neoplasms1
2RecruitingTreatmentBiliary Tract Cancer / Cancer of the Gallbladder / Cholangiocarcinomas1
2, 3RecruitingTreatmentBiliary Tract Cancer / Cancer of the Gallbladder / Cholangiocarcinomas1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 09:23 / Updated on March 01, 2020 22:06

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates